MedPath

Glasgow Natural History Study Of Covered Coronary Interventions

Completed
Conditions
Coronary Artery Perforation
Coronary Stent Occlusion
Stent Thrombosis
Interventions
Device: Covered coronary stent
Registration Number
NCT03862352
Lead Sponsor
NHS National Waiting Times Centre Board
Brief Summary

Covered stents (CS) are a potentially lifesaving treatment for grade III coronary perforation but delivery can be challenging, and the long-term durability and safety including risk of acute stent thrombosis are unknown. The GNOCCI study aims to evaluate long term outcomes after coronary perforation including patients treated with covered stents.

Detailed Description

Covered stents (CS) are a potentially lifesaving treatment for grade III coronary perforation but delivery can be challenging, and the long-term durability and safety including risk of acute stent thrombosis are unknown. Using an electronic data base, details of all coronary perforations are identified and anonymised patient and procedural details are recorded.Procedural major adverse cardiac events (pMACE) are defined as a composite of death, myocardial infarction, stroke, target vessel revascularization or cardiac surgery within 24 hours of the index procedure. Two independent cardiologists adjudicate outcomes and differences in opinion are resolved by consensus with a third cardiologist.

The overall GNOCCI study aims are:

1. Evaluate procedural and long term outcomes after coronary perforation

2. Long term safety and clinical events in patients treated with covered stents.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
161
Inclusion Criteria
  • Any coronary artery perforation during percutaneous coronary intervention
Exclusion Criteria
  • Nil

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Coronary artery perforation (iatrogenic)Covered coronary stentAny coronary artery perforation defined according to the Ellis criteria.
Primary Outcome Measures
NameTimeMethod
Procedural major adverse cardiac events (pMACE)24 hours of the index procedure.

Defined as a composite of death, myocardial infarction, stroke, target vessel revascularization or cardiac surgery

Secondary Outcome Measures
NameTimeMethod
Stent thrombosisUp to 10 years

ARC definite or probable

MACEUp to 10 years

death, myocardial infarction, stroke, target vessel revascularization or cardiac surgery

Unsuccessful covered stent deployment24 hours of the index procedure.

Attempted covered stent insertion without sealing of perforation, defined by case review of two independent cardiologists from source files

Trial Locations

Locations (1)

Golden Jubilee National Hospital

🇬🇧

Glasgow, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath